Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Ariel M. Ley Clear advanced filters
  • Vijayanand and colleagues show highly suppressive CD4+CTLA-4+PD-1+ follicular regulatory T (TFR) cells reside within tumor microenvironments. Depleting TFR cells or blocking their activity with CTLA-4-depleting antibodies before anti-PD-1 checkpoint blockade therapy improved the efficacy of anti-PD-1 treatment in mouse tumor models and was also associated with better survival outcomes in a large cohort of patients with melanoma.

    • Simon Eschweiler
    • James Clarke
    • Pandurangan Vijayanand
    Research
    Nature Immunology
    Volume: 22, P: 1052-1063
  • Sanz and colleagues examine B cell subsets in a cohort of patients with COVID-19. Severely ill patients have higher frequencies of activated extrafollicular T-bet+ B cells that form antibody-secreting cells, the majority of which express germline sequences and are reminiscent of antibody responses observed in patients with systemic lupus erythematosus during flares.

    • Matthew C. Woodruff
    • Richard P. Ramonell
    • Ignacio Sanz
    Research
    Nature Immunology
    Volume: 21, P: 1506-1516